Topics

Reapplix Company Profile

05:29 EDT 17th September 2019 | BioPortfolio

Reapplix has developed a novel platform technology for regenerative medicine which provides cells and growth factors concentrated from a small sample of the patient’s own blood and addresses unmet needs in tissue healing.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Reapplix

Reapplix has developed a novel platform technology for regenerative medicine which provides cells and growth factors concentrated from a small sample of the patient’s own blo...

More Information about "Reapplix" on BioPortfolio

We have published hundreds of Reapplix news stories on BioPortfolio along with dozens of Reapplix Clinical Trials and PubMed Articles about Reapplix for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Reapplix Companies in our database. You can also find out about relevant Reapplix Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record